Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2016
EPIC Early Detection of Ovarian CancerSteven J Skates
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2012
Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trialsSteven J Skates
Cancer Discovery|November 1, 2024
Combination Diagnostics: Adding Blood-Based ctDNA Screening to Low-Dose CT Imaging for Early Detection of Lung CancerDaniel A Haber, Steven J Skates
Arxiv|February 24, 2025
Advancing Precision Oncology Through Modeling of Longitudinal and Multimodal DataLuoting Zhuang, Stephen H Park, Steven J Skates, et al.
IEEE Reviews in Biomedical Engineering|July 3, 2025
Advancing Precision Oncology Through Modeling of Longitudinal and Multimodal DataLuoting Zhuang, Stephen H Park, Steven J Skates, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2022
Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening StudiesSana Raoof, Richard J Lee, Kunal Jajoo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2011
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?Jenette Creaney, Deborah Yeoman, Arthur William Musk, et al.
Gynecologic Oncology|March 30, 2004
Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samplesRichard T Penson, Esther Oliva, Steven J Skates, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesotheliomaJenette Creaney, Deborah Yeoman, Yvonne Demelker, et al.
Disease Markers|December 16, 2014
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesotheliomaJenette Creaney, Amanda Segal, Nola Olsen, et al.
Pageof 9